Levemir
- Product NDC
- 70518-1462
- 11-digit product format
- 705181462
- Labeler code
- 70518
- Product ID
- 70518-1462_c2b05115-161f-7c65-e053-2995a90a13fd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- insulin detemir
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- REMEDYREPACK INC.
- Application
- BLA021536
- Marketing category
- BLA
- Marketing start
- 2018-10-04
- Marketing end
- 0000-00-00
- Substance
- INSULIN DETEMIR
- Active strength
- 100 [iU]/mL
- Pharmacologic classes
- Insulin [Chemical/Ingredient],Insulin Analog [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-1462-0 | 70518146200 | 1 VIAL, GLASS in 1 CARTON (70518-1462-0) > 10 mL in 1 VIAL, GLASS | 2018-10-04 | 0000-00-00 | No | No | Current |